Arrowstreet Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$42.2K Sell
2024
Q3
$112K Buy
2021
Q4
Sell
2021
Q3
$1.49M Buy
2021
Q2
$330K Buy
2021
Q1
Sell
2020
Q4
$6.33M Buy
2020
Q3
$1.36M Buy
2020
Q1
Sell
2019
Q4
$624K Buy
2019
Q2
Sell
2019
Q1
$339K Buy
2018
Q4
$138K Buy